ArticleBMC complementary medicine and therapies2024

Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.

Xiaoliang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.